EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review

Matthew H Lanehart, Erika S Johnson, Nicole A Aqui

Journal of Clinical Apheresis · 2024

DOI: 10.1002/jca.22153 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Apheresis, 2024. Verfasst von Matthew H Lanehart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Scleromyxedema, Plasma Exchange. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleromyxedema is a rare skin mucinosis often associated with systemic involvement and monoclonal gammopathy (MG). No formal recommendation for management with therapeutic plasma exchange (TPE) has been published due to rarity. This paper reports a 42‐year‐old male with progressive scleromyxedema. The patient was treated with glucocorticoids, immunosuppressants, and intravenous immunoglobulin (IVIG) therapy, but the disease progressed. Ultimately, the patient was referred for TPE, which resulted in decreased skin stiffness, improved extremity range of motion, and decreased visibility of papules on the hands. The patient's debilitating dysphagia gradually improved. A review of the literature focusing on clinical response identified five cases of scleromyxedema patients treated with TPE. Three of the five cases reported significant improvement in cutaneous symptoms and range of motion for at least 12 months. Overall, we propose that TPE should be considered an effective supportive treatment for symptomatic relief in severe or refractory scleromyxedema.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ScleromyxedemaPlasma ExchangeHumansAdultMaleImmunoglobulins, IntravenousTreatment OutcomeImmunosuppressive Agents

Stichwörter der Autor:innen

TPEmonoclonal gammopathymyopathypapular mucinosisscleromyxedema

Substanzen

Immunoglobulins, IntravenousImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • West Virginia University School of Medicine, Morgantown, West Virginia, USA.

Zitieren

APA

Lanehart, M. H., Johnson, E. S., & Aqui, N. A. (2024). Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22153

Vancouver

Lanehart MH, Johnson ES, Aqui NA. Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. 2024. doi:10.1002/jca.22153

BibTeX
@article{Lanehart2024,
  author = {Lanehart, Matthew H and Johnson, Erika S and Aqui, Nicole A},
  title = {Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review},
  journal = {Journal of Clinical Apheresis},
  year = {2024},
  doi = {10.1002/jca.22153}
}
Kostenlos starten →